#1 · 196170
Alteogen Inc.9.12%
Compare TIGER Out-licensing Bio Active (0168K0) holdings, returns, price versus NAV and estimated fund flows. See each data date on the page.
Returns are negative over every period shown. The premium/discount is within 1%.
Estimated money has flowed in for 4 straight sessions. 25 of the last 58 sessions (43%) saw net inflows and 24 saw net outflows.
| Date | Estimated net flow |
|---|---|
| 2026-10-15 | — |
| 2026-10-14 | — |
| 2026-10-13 | +₩250M |
| 2026-10-12 | +₩839M |
| 2026-10-08 | +₩329M |
| 2026-10-07 | +₩2.0B |
| 2026-10-06 | -₩704M |
| 2026-10-02 | -₩745M |
| 2026-10-01 | -₩1.2B |
| 2026-09-30 | -₩873M |
| 2026-09-29 | -₩1.1B |
| 2026-09-28 | ₩0 |
| 2026-09-23 | +₩1.6B |
| 2026-09-22 | ₩0 |
| 2026-09-21 | +₩275M |
| 2026-09-18 | -₩557M |
| 2026-09-17 | -₩859M |
| 2026-09-16 | ₩0 |
| 2026-09-15 | -₩284M |
| 2026-09-14 | +₩112M |
| 2026-09-11 | -₩344M |
| 2026-09-10 | +₩116M |
| 2026-09-09 | +₩885M |
| 2026-09-08 | +₩59M |
| 2026-09-07 | -₩540M |
| 2026-09-04 | ₩0 |
| 2026-09-03 | +₩644M |
| 2026-09-02 | +₩607M |
| 2026-09-01 | +₩1.4B |
| 2026-08-31 | +₩700M |
| 2026-08-27 | -₩65M |
| 2026-08-26 | -₩196M |
| 2026-08-25 | +₩776M |
| 2026-08-24 | +₩132M |
| 2026-08-21 | -₩944M |
| 2026-08-20 | -₩271M |
| 2026-08-19 | -₩849M |
| 2026-08-18 | +₩1.0B |
| 2026-08-14 | -₩615M |
| 2026-08-13 | ₩0 |
| 2026-08-12 | ₩0 |
| 2026-08-11 | +₩425M |
| 2026-08-10 | +₩72M |
| 2026-08-07 | +₩1.8B |
| 2026-08-06 | +₩593M |
| 2026-08-05 | +₩2.0B |
| 2026-08-04 | -₩64M |
| 2026-08-03 | -₩862M |
| 2026-07-31 | ₩0 |
| 2026-07-30 | ₩0 |
| 2026-07-29 | -₩52M |
| 2026-07-28 | -₩787M |
| 2026-07-27 | -₩1.0B |
| 2026-07-24 | -₩4.2B |
| 2026-07-23 | ₩0 |
| 2026-07-22 | -₩280M |
| 2026-07-21 | +₩57M |
| 2026-07-20 | -₩3.3B |
| 2026-07-16 | +₩871M |
| 2026-07-15 | +₩63M |
The top 5 holdings make up 38.8% of the fund, and the top 10 63.5%.
| # | Holding | Weight | Status |
|---|---|---|---|
| 1 | Alteogen Inc. 196170 | 9.12% | |
| 2 | OliX Pharmaceuticals, Inc. 226950 | 8.34% | |
| 3 | Hanmi Pharm. Co., Ltd. 128940 | 8.21% | |
| 4 | KRW Cash 010010 | 7.66% | |
| 5 | Celltrion, Inc. 068270 | 5.48% | |
| 6 | LigaChem Biosciences Inc. 141080 | 5.37% | |
| 7 | G2GBIO, Inc. 456160 | 5.07% | |
| 8 | HANALL BIOPHARMA CO.,LTD 009420 | 4.85% | |
| 9 | ABL Bio Inc. 298380 | 4.81% | |
| 10 | OSCOTECInc. 039200 | 4.58% | |
| 11 | Rznomics Inc. 476830 | 4.37% | |
| 12 | ST PHARM CO., LTD. 237690 | 4.19% | |
| 13 | AbClon Inc. 174900 | 3.99% | |
| 14 | D&D Pharmatech Inc. 347850 | 2.76% | |
| 15 | BUKWANG PHARMACEUTICAL IND CO.,LTD 003000 | 2.71% | |
| 16 | SAMSUNG BIOLOGICS CO.,LTD. 207940 | 2.40% | |
| 17 | HLB innoVation Co.,Ltd. 024850 | 2.30% | |
| 18 | AprilBio Co.,Ltd. 397030 | 1.68% | |
| 19 | PharmaResearch Co., Ltd. 214450 | 1.65% | |
| 20 | PROTEINA CO.,LTD. 468530 | 1.63% | |
| 21 | YUHAN CORPORATION 000100 | 1.62% | |
| 22 | Voronoi, Inc. 310210 | 1.44% | |
| 23 | Onconic Therapeutics Inc. 476060 | 1.25% | |
| 24 | 3billion Inc. 394800 | 1.14% | |
| 25 | NEXTBIOMEDICAL Co., Ltd. 389650 | 1.09% | |
| 26 | SK biopharmaceuticals Co., Ltd. 326030 | 0.71% | |
| 27 | IntoCell, Inc. 287840 | 0.58% | |
| 28 | Orum Therapeutics, Inc. 475830 | 0.32% | |
| 29 | MEDIPOSTCO.,LTD. 078160 | 0.25% | |
| 30 | Y-Biologics, Inc 338840 | 0.21% | |
| 31 | GENINUS Inc. 389030 | 0.11% | |
| 32 | Samyang Biopharm Corporation 0120G0 | 0.09% | |
| 33 | GI Innovation Inc. 358570 | 0.02% |